source
- Vaxcyte's experimental pneumococcal vaccine meets primary endpoints in Phase 3 trialVaxcyte announced that its experimental pneumococcal vaccine, VAX-31, achieved the primary endpoints in a Phase 3 trial. The study enrolled just over 3,500 adults aged 50 and older who were random…
- 2026 Nobel Prize in Medicine awarded for optogenetics, the light-controlled brain research toolKarl Deisseroth, Peter Hegemann and Georg Nagel were named the 2026 Nobel laureates in Physiology or Medicine for their work on light-gated ion channels and the optogenetics technique. The Karolins…